NCT05382494 - Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

December 5, 2022

Primary Completion Date

July 17, 2025

Study Completion Date

July 17, 2025

Conditions

Sleep Disorder; Breathing-RelatedSnoringObstructive Sleep Apnea of ChildSleep Disorders in ChildrenTonsillar HypertrophyAdenoidal Disorder

Interventions

DRUG

Mometasone Furoate 50mcg Nasal Spray

Intranasal steroid (Mometasone Furoate 50mcg) one spray each nostril daily for 6 weeks

DRUG

Sodium Chloride 0.9 % Nasal Spray

Intranasal saline spray (Sodium Chloride 0.9%) one spray each nostril daily for 6 weeks

Trial Locations (2)

Royal Children's Hospital / Murdoch Children's Research Institute, Parkville

Monash Children's Hospital, Clayton